chevron_leftBack
As of 15 June 2026, Sunflower Pharmaceutical Group Co.,Ltd has a market cap of $1.13B USD, ranking #10023 globally and #2764 in China.
It ranks #881 in the Healthcare sector, and #332 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.13BUSD
7.65B CNY
Enterprise Value
$784.73MUSD
5.31B CNY
Revenue (TTM)
$342.52MUSD
2.32B CNY
EBITDA (TTM)
-$6.46MUSD
-43.71M CNY
Net Income (TTM)
-$38.1MUSD
-257.83M CNY
EBITDA Margin
-1.9%
Profit Margin
-11%
PS Ratio
3.3
PB Ratio
1.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yi Guan
open_in_new
Employees
5,727
Founded
2005
Website
kuihuayaoye.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 6% | 15% | 12% | -3.5% | -4.9% | -11% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002737
葵花药业集团股份有限公司 Class A
ISIN: CNE100001WT7
Shares Out.:
Shares Outstanding:
584.0M1
Shares Float:
210.634M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.88 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, adult digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; tonic; and antibiotics and children’s medicinal products. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is based in Harbin, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.92B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.7B
4K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.53B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
67K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
48K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
32K%
|
97.4
|
|
SIX: RO
|
$321.52B
28K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
25K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
24K%
218.9B CHF
|
20.5
|
chevron_leftBack